A paper showing the efficacy of CoV-mMAP, a mutation-compatible Multiple Antigen Peptides for Universal Coronavirus produced by our technology source, against feline infectious peritonitis was published in Veterinary Vaccine. CoV-mMAP is under research and development as a universal coronavirus therapeutic vaccine for humans and various animals.